Anti-Lipidemic Effect of Combined Leaf Extracts of Moringa oleifera and Peristrophe bicalyculata in Alloxan-Induced Diabetic Rats

I. A. Iwara, G. O. Igile, I. P. Ogar, O. E. Mboso, U. P. Ujong, E. U. Eyong, P. E. Ebong

Department of Biochemistry, Faculty of Basic Medical Sciences, Cross River State University of Technology, Calabar, Nigeria.
Department of Biochemistry, Faculty of Basic Medical Sciences, University of Calabar, Calabar, Nigeria.

DOI: 10.4236/pp.2014.54041                

Abstract

In this study, the anti-lipidemic effects of combined extracts of Moringa oleifera and Peristrophe bicalyculata in allxoan-induced diabetic rats were investigated. Fifty four (54) adult male albino Wistar rats weighing between 140-180 g were shared into 5 parallel groups consisting of diabetic (DC) and non-diabetic (NC) groups. Each group consisted of 6 rats. Groups 2-5 were made diabetic using alloxan (150 mg/kg b.w in distil H₂O). Except for groups 1 and 2, animals were gavaged at doses of 500 mg/kg b.w for the single dose of extract and 250 mg/kg for the combine extract treatment. Insulin served as a standard drug and was administered at 5IU/kg b.w. The control animal groups (NC, DC) received 0.2 ml of normal saline (placebo) for fourteen (14) consecutive days. Groups treated with extracts showed a significant (p < 0.05) increase in triglyceride (TG), total cholesterol (TC) levels, very low density lipoprotein (VLDL) and low density lipoprotein (LDL mg/dl) concentrations in all treated groups compared to the diabetic control group. No significant (p > 0.05) change was observed in HDL-C level in treated groups when compared to the normal control, diabetic control and insulin groups, suggesting a potential protection against cardiovascular diseases (CVDs) by these plants. No reduction in body weight was observed within the experimental period of 14 days. The results obtained in this study are in agreement with several other research results with these plants and claims by ethno-medical practitioners on the use of Moringa oleifera and Peristrophe bicalyculata in the treatment of hypertension and related CVDs.

Keywords

Diabetes; Anti-Lipidemia; Cholesterol; Moringa oleifera; Peristrophe bicalyculata; Hypertension

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Greenbaum, C.J. and Harrison, L.C., Eds. (2008) Diabetes: Translating Research into Practice. Informa Healthcare, London, 1-2.
[2]	Fonseca, V.A. (2006) Clinical Diabetes: Translating Research into Practice. Saunders Elsevier, Philadelphia, 2-3.
[3]	Chandramohan, G., Ignacimuthu, S. and Pugalendi, K.V. (2008) A Novel Compound from Casearia esculenta (Roxb.) Root and Its Effect on Carbohydrate Metabolism in Streptozotocin-Diabetic Rats. European Journal of Pharmacology, 590, 437-443. http://dx.doi.org/10.1016/j.ejphar.2008.02.082
[4]	Kim, S.H., Hyun, S.H. and Choung, S.Y. (2006) Anti-Diabetic Effect of Cinnamon Extract on Blood Glucose in db/db Mice. Journal of Ethnopharmacology, 104, 119-123. http://dx.doi.org/10.1016/j.jep.2005.08.059
[5]	Ramachandran, C., Peter, K.V. and Gopalakrishnan, P.K. (1980) Drumstick (Moringa oleifera) a Multipurpose Indian Vegetable. Economic Botany, 34, 276-283. http://dx.doi.org/10.1007/BF02858648
[6]	Fuglie, L.J. (1999) The Miracle Tree: Moringa oleifera: Natural Nutrition for the Tropics. Church World Service, Dakar, 68.
[7]	Anwar, F., Ashraf, M. and Bhanger, M.I. (2005) Interprovenance Variation in the Composition of Moringa oleifera Oilseeds from Pakistan. Journal of the American Oil Chemists’ Society, 82, 45-51.
[8]	Mughal, M.H, Ali, G., Srivastava, P.S. and Iqbal, M. (1999) Improvement of Drumstick (Moringa pterygosperma Gaertn.)—A Unique Source of Food and Medicine through Tissue Culture. Hamdard Medicus, 42, 37-42.
[9]	Siddhuraju, P. and Becker, K. (2003) Antioxidant Properties of Various Solvent Extracts of Total Phenolic Constituents from Three Different Agroclimatic Origins of Drumstick Tree (Moringa oleifera Lam.) Leaves. Journal of Agricultural and Food Chemistry, 51, 2144-2155. http://dx.doi.org/10.1021/jf020444+
[10]	Caceres, A., Cebreva, O., Morales, O., Miollinedo, P. and Mendia, P. (1991) Pharmacological Properties of Moringa oleifera: Preliliminary Screening for Antimicrobial Activity. Journal of Ethnopharmacology, 33, 213-216. http://dx.doi.org/10.1016/0378-8741(91)90078-R
[11]	Limaye, D.A., Nimbakar, A.Y., Jain, R. and Mansoor, A. (1995) Cardiovascular Effects of Aqueous Extract of Moringa pterygosperma. Phytotherapy Research, 9, 37-40. http://dx.doi.org/10.1002/ptr.2650090109
[12]	Ghasi, S., Nwobodo, E. and Ofili, J.O. (2000) Hypocholesterolemic Effects of Crude Extract of Leaf of Moringa oleifera Lam. in High Fat Diet Fed Wistar Rats. Journal of Ethnopharmacology, 69, 21-25. http://dx.doi.org/10.1016/S0378-8741(99)00106-3
[13]	Gupta, M., Mazumdar, U.K. and Chakrabarti, S. (1999) CNS Activities of Methanolic Extract of Moringa oleifera Root in Mice. Fitoterapia, 70, 244-250. http://dx.doi.org/10.1016/S0367-326X(99)00029-5
[14]	Guevara, A.P., Vargas, C., Sakurai, H., Fuziwara, Y., Hashimoto, K. and Maoka, T. (1999) An Anti-Tumor Promoter from Moringa oleifera Lam. Mutation Research, 440, 181-188. http://dx.doi.org/10.1016/S1383-5718(99)00025-X
[15]	Ruckmani, K., Kacimani, S., Anandan, R. and Jaykar, B. (1998) Effect of Moringa oleifera Lam. on Paracetamol-Induced Hepatotoxicity. Indian Journal of Pharmaceutical Sciences, 60, 33-35.
[16]	Pal, S.K., Mukherjee, P.K. and Saha, B.P. (1995) Studies on the Antiulcer Activity of Moringa oleifera Leaf Extract on Gastric Ulcer Models in Rats. Phytotherapy Research, 9, 463-465. http://dx.doi.org/10.1002/ptr.2650090618
[17]	Dwivedi, S. and Gupta, D. (2002) Efficacy of Terminalia arjuna in Chronic Stable Angina. Indian Heart Journal, 54, 441.
[18]	Dwivedi, S. (2008) Ethnomedicinal Uses of Some Plant Species by Ethnic and Rural Peoples of Indore District of Madhya Pradesh, India. http://www.pharmainfo.net/
[19]	Yokozawa, T., Ishida, A., Cho, E.J. and Nakagawa, T. (2003) The Effects of Coptidis rhizoma Extract on a Hypercholesterolemia Animal Model. Phytomedicine, 10, 17-22. http://dx.doi.org/10.1078/094471103321648610
[20]	Farias, R.A.F., Neto, M.F.O., Viana, G.S.B. and Rao, V.S.N.I. (1996) Effects of Croton cajucara Extract on Serum Lipids of Rats Fed a High Fat Diet. Phytotherapy Research, 10, 697-699. http://dx.doi.org/10.1002/(SICI)1099-1573(199612)10:8<697::AID-PTR925>3.0.CO;2-I
[21]	Efiong, E.E., Iwara, A.I., Igile, G.U., Edet, E.E., Ebong, P.E. and Itam, E.H. (2013) Combined Leaves Extract of Moringa oleifera and Ocimum gratissimum Ameliorated Diabetes Induced Hyperlipidemia in Diabetic Wistar Rats. International Journal of Biochemistry. Photon, 108, 249-254.
[22]	Lorke, D. (1983) A New Approach to Practical Acute Toxicity Testing. Archives of Toxicology, 53, 275-287. http://dx.doi.org/10.1007/BF01234480
[23]	Castelli, L. (1984) Epidemiology of Coronary Heart Disease. American Journal of Medicine, 76, 4-12. http://dx.doi.org/10.1016/0002-9343(84)90952-5
[24]	Turpanen, O. (1979) Effect of Cholesterol Lowering Diet on Mortality from Coronary Heart Disease and Other Causes. Circulation, 59, 1-7. http://dx.doi.org/10.1161/01.CIR.59.1.1
[25]	Gotto, A.M.J. (1998) Triglyceride: The Forgotten Risk Factor. Circulation, 97, 1027-1028. http://dx.doi.org/10.1161/01.CIR.97.11.1027
[26]	Evans, M., Roberts, A., Davies, S. and Rees, A. (2004) Medical Lipid Regulating Therapy: Current Evidence, Ongoing Trials and Future Developments. Drugs, 64, 1181-1196. http://dx.doi.org/10.2165/00003495-200464110-00003
[27]	Hokanson, J.E. and Austen, M.A. (1996) Plasma Triglyceride Level Is a Risk Factor for Cardiovascular Disease Independent of High Density Lipoprotein Cholesterol Levels: A Meta-Analysis of Population Based Prospective Studies. Journal of Cardiovascular Risk, 3, 213. http://dx.doi.org/10.1097/00043798-199604000-00014
[28]	Ohlsen, S. and Rogers, D. (2004) Reducing Hyperlipideamia and CHD. The Pharmaceutical Journal, 273, 116-118.
[29]	Atangwho, I.J., Ebong, P.E., Eyong, M.U., Eteng, M.U. and Uboh, F.E. (2007) Vernonia amygdalina Del.: A Potential Prophylactic Antidiabetic Agent in Lipids Complication. Global Journal of Pure and Applied Sciences, 13, 103-106. http://dx.doi.org/10.4314/gjpas.v13i1.16677
[30]	Zafar, M., Naeem-ul-Hassan Naqvi, S., Ahmed, M. and Kaim Khani, Z. (2009) Altered Liver Morphology and Enzymes in Streptozotocin Induced Diabetic Rats. International Journal of Morphology, 27, 719-725.
[31]	Cotran, R.S., Kumar, V. and Collins, T. (1999) Robbins Pathologic Basis of Disease. 6th Edition, W. B. Saunders Coy, Philadelphia.
[32]	Nagarajan, N.S., Murugesh, N., Thirupathy Kumaresan, P., Radha, N. and Murali, A. (2005) Antidiabetic and Antihyperlipemic Effects of Clemeo feline. Fitoterapia, 76, 310-315. http://dx.doi.org/10.1016/j.fitote.2005.03.020